These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24286190)

  • 1. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study.
    Wallis D; Asaduzzaman A; Weisman M; Haroon N; Anton A; McGovern D; Targan S; Inman R
    Arthritis Res Ther; 2013 Oct; 15(5):R166. PubMed ID: 24286190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study.
    Mundwiler ML; Mei L; Landers CJ; Reveille JD; Targan S; Weisman MH
    Arthritis Res Ther; 2009; 11(6):R177. PubMed ID: 19930665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.
    Matzkies FG; Targan SR; Berel D; Landers CJ; Reveille JD; McGovern DP; Weisman MH
    Arthritis Res Ther; 2012 Nov; 14(6):R261. PubMed ID: 23194008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relevance of serologic studies in inflammatory bowel diseases].
    Papp M; Altorjay I; Lakatos PL
    Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Bowel Disease Serological Immune Markers Anti-Saccharomyces cerevisiae Mannan Antibodies and Outer Membrane Porin C are Potential Biomarkers for Hirschsprung-associated Enterocolitis.
    Frykman PK; Patel DC; Kim S; Cheng Z; Wester T; Nordenskjöld A; Kawaguchi A; Hui TT; Ehrlich PF; Granström AL; Benliyan F;
    J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):176-181. PubMed ID: 30964819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease.
    Yu JE; De Ravin SS; Uzel G; Landers C; Targan S; Malech HL; Holland SM; Cao W; Harpaz N; Mayer L; Cunningham-Rundles C
    Clin Immunol; 2011 Jan; 138(1):14-22. PubMed ID: 20956091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.
    de Vries M; van der Horst-Bruinsma I; van Hoogstraten I; van Bodegraven A; von Blomberg BM; Ratnawati H; Dijkmans B
    J Rheumatol; 2010 Nov; 37(11):2340-4. PubMed ID: 20810508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to CBir1 are associated with glycogen storage disease type Ib.
    Davis MK; Valentine JF; Weinstein DA; Polyak S
    J Pediatr Gastroenterol Nutr; 2010 Jul; 51(1):14-8. PubMed ID: 20410847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
    Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
    J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
    Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
    Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [No Abstract]   [Full Text] [Related]  

  • 17. Serological markers in inflammatory bowel diseases.
    Reumaux D; Sendid B; Poulain D; Duthilleul P; Dewit O; Colombel JF
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):19-35. PubMed ID: 12617880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
    Montanelli A; Mainardi E; Vagni A; Villanacci V; Zambelli C; Cestari R; Cengia P; Minelli L; Missale G
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):201-7. PubMed ID: 15990710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
    Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
    Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.